These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6171429)

  • 21. Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization.
    Puccetti P; Bianchi R; Romani L; Cenci E; Fioretti MC
    Int J Cancer; 1989 Feb; 43(2):279-84. PubMed ID: 2465277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologically defined antigens on the surface of somatic hybrid cells.
    Rubio N
    Int Arch Allergy Appl Immunol; 1982; 67(2):123-6. PubMed ID: 7056591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in MHC antigenic profiles of tumor cells and its biological effects.
    Festenstein H; Schmidt W
    Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
    [No Abstract]   [Full Text] [Related]  

  • 26. Alloantisera reacting with tumor cells of inappropriate haplotype. I. Characterization of target antigens.
    Prat M; Rogers MJ; Appella E
    J Natl Cancer Inst; 1978 Aug; 61(2):527-34. PubMed ID: 79659
    [No Abstract]   [Full Text] [Related]  

  • 27. Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity.
    Schirrmacher V; Bosslet K
    Cancer Immunol Immunother; 1982; 13(1):62-8. PubMed ID: 7159873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic cross-reactivity of antigen(s) induced by drug treatment in two leukemic sublines.
    Nicolin A; Bini A; Di Padova F; Goldin A
    J Immunol; 1976 May; 116(5):1347-9. PubMed ID: 58028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.
    Giampietri A; Fioretti MC; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1980 Feb; 64(2):297-301. PubMed ID: 6928222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obtention of Sm antigen from L5178 murine lymphoma malignant cells.
    Lamas-Robles C; Mejía-Arreguín S; Gómez-Estrada H; González-Mendoza A
    Arch Invest Med (Mex); 1984; 15(3):259-65. PubMed ID: 6443059
    [No Abstract]   [Full Text] [Related]  

  • 33. Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels.
    Troy FA; Fenyö EM; Klein G
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5270-4. PubMed ID: 74831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
    Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
    J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A search for target cell structures associated with susceptibility to NK cells.
    Henney CS
    Adv Exp Med Biol; 1982; 146():357-66. PubMed ID: 7102463
    [No Abstract]   [Full Text] [Related]  

  • 37. A serologically detected tumour-specific membrane antigen of murine lymphomas which is not the target for syngeneic graft rejection.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1979 Jul; 40(1):168-70. PubMed ID: 89857
    [No Abstract]   [Full Text] [Related]  

  • 38. [Humoral autoimmune reactions directed against autoantigens of the H-2 histocompatibility system in mice with developing Rauscher leukemia].
    Ter-Griggorov VS; Moskovkina OIa; Krupnik VE; Graf IA; Pivnik AV
    Eksp Onkol; 1988; 10(6):21-5. PubMed ID: 2468468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L
    Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic properties of solubilized tumour antigen from an RNA virus-transformed neoplasm.
    Law LW; Apella E
    Nature; 1973 May; 243(5402):83-7. PubMed ID: 4122415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.